Outpatient convalescent plasma therapy for high-risk patients with early COVID-19. A randomized placebo-controlled trial
Gharbharan et al., Clinical Microbiology and Infection, doi:10.1016/j.cmi.2022.08.005
https://c19early.org/gharbharan2.html